SUNNYVALE, CA–(Marketwired – May 23, 2017) – Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s health, today announced that it has entered into a senior credit facility with affiliates of CRG LP to retire its existing credit facility and provide additional capital for the company. The new credit facility consists

Term Loans Support Commercialization in Europe and U.S. Regulatory Clearance and Market Development May 10, 2017 04:02 PM Eastern Daylight Time RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–TransEnterix, Inc. (NYSE MKT:TRXC) (the “Company”), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it has entered into a

Study Results Confirm Overall Antifungal Activity of Oral SCY-078 in Patients with Candida Infections Well-Tolerated and Active Oral Dose of SCY-078 Identified for Invasive Candidiasis Patients Evidence of Efficacy and Lower Relapse Rates versus Standard of Care in VVC Patients Strong Cash Position to Accelerate and Expand Development of SCY-078 in Multiple Indications   JERSEY

MINNEAPOLIS, Aug. 9, 2016 /PRNewswire/ — CVRx, Inc., a private medical device company, has secured equity financing totaling $93 million and a new $20 million debt facility.  CVRx plans to use the proceeds for the primary purposes of completing the Baroreflex Activation Therapy for Heart Failure Pivotal Clinical Trial (BeAT-HF) and expanding its global commercial activities.